Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$1.45 - $2.79 $3,335 - $6,417
-2,300 Closed
0 $0
Q4 2018

Jan 28, 2019

BUY
$2.77 - $9.38 $6,371 - $21,574
2,300 New
2,300 $6,000

Others Institutions Holding IDRA

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About IDERA PHARMACEUTICALS, INC.


  • Ticker IDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,296,900
  • Market Cap $188M
  • Description
  • Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...
More about IDRA
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.